Table 2

Results of analysis on day 28

Amlodipine group (mean±SD)Control group (mean±SD)Mean difference (95% CI)p Value
Platelet reactivity unit (primary end-point)227±84214±9012.7 (−22 to +47)0.47
Platelet inhibition, % (secondary end-point)33±2238±25−4.5 (−14 to +5.0)0.34
No. of poor responder to clopidogrel, n (%) (secondary end-point)24 (49%)22 (45%)0.76